Switch theme
Sign up to access all valuation multiples
Universal Vision Biotechnology Co Ltd is mainly engaged in operating the business of sales of optical devices, glasses, lenses, and other vision aid products; optometric services; sales and leasing of medical devices; and providing hospital management and technical consultancy services. The company's reportable segments include its Ophthalmology Business segment and the Optometry Business segment. A majority of its revenue is generated from the Ophthalmology Business segment, which is responsible for providing ophthalmic clinics and hospital technical services and consultancy services, and leasing services. The Optometry Business segment is responsible for the sales of glasses and peripheral equipment. Geographically, the company derives maximum revenue from Taiwan and the rest from China.
1994
325
LTM Revenue $145M
LTM EBITDA $64.5M
$546M
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
Universal Vision has a last 12-month revenue (LTM) of $145M and a last 12-month EBITDA of $64.5M.
In the most recent fiscal year, Universal Vision achieved revenue of $141M and an EBITDA of $62.1M.
Universal Vision expects next 12-month revenue of XXX and NTM EBITDA of XXX
See Universal Vision valuation multiples based on analyst estimates| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue | $145M | XXX | $141M | XXX | XXX | XXX |
| Gross Profit | $85.9M | XXX | $84.5M | XXX | XXX | XXX |
| Gross Margin | 59% | XXX | 60% | XXX | XXX | XXX |
| EBITDA | $64.5M | XXX | $62.1M | XXX | XXX | XXX |
| EBITDA Margin | 44% | XXX | 44% | XXX | XXX | XXX |
| EBIT | $47.8M | XXX | $46.7M | XXX | XXX | XXX |
| EBIT Margin | 33% | XXX | 33% | XXX | XXX | XXX |
| Net Profit | $37.5M | XXX | $35.5M | XXX | XXX | XXX |
| Net Margin | 26% | XXX | 25% | XXX | XXX | XXX |
| Net Debt | XXX | XXX | n/a | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of May 30, 2025, Universal Vision's stock price is TWD 209 (or $7).
Universal Vision has current market cap of TWD 17.7B (or $592M), and EV of TWD 16.4B (or $546M).
See Universal Vision trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $546M | $592M | XXX | XXX | XXX | XXX | $0.44 |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Start Free TrialAs of May 30, 2025, Universal Vision has market cap of $592M and EV of $546M.
Universal Vision's trades at 3.9x EV/Revenue multiple, and 8.8x EV/EBITDA.
Equity research analysts estimate Universal Vision's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Universal Vision has a P/E ratio of 15.8x.
See valuation multiples for Universal Vision and 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $592M | XXX | $592M | XXX | XXX | XXX |
| EV (current) | $546M | XXX | $546M | XXX | XXX | XXX |
| EV/Revenue | 3.8x | XXX | 3.9x | XXX | XXX | XXX |
| EV/EBITDA | 8.5x | XXX | 8.8x | XXX | XXX | XXX |
| EV/EBIT | 11.4x | XXX | 11.7x | XXX | XXX | XXX |
| EV/Gross Profit | 6.3x | XXX | n/a | XXX | XXX | XXX |
| P/E | 15.8x | XXX | 16.7x | XXX | XXX | XXX |
| EV/FCF | 19.2x | XXX | 13.2x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Start Free TrialUniversal Vision's last 12 month revenue growth is 7%
Universal Vision's revenue per employee in the last FY averaged $0.4M, while opex per employee averaged $0.1M for the same period.
Universal Vision's rule of 40 is 51% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Universal Vision's rule of X is 62% (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
See operational valuation multiples for Universal Vision and other 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue Growth | 7% | XXX | 7% | XXX | XXX | XXX |
| EBITDA Margin | 44% | XXX | 44% | XXX | XXX | XXX |
| EBITDA Growth | 1% | XXX | 7% | XXX | XXX | XXX |
| Rule of 40 | 51% | XXX | 51% | XXX | XXX | XXX |
| Bessemer Rule of X | XXX | XXX | 62% | XXX | XXX | XXX |
| Revenue per Employee | XXX | XXX | $0.4M | XXX | XXX | XXX |
| Opex per Employee | XXX | XXX | $0.1M | XXX | XXX | XXX |
| S&M Expenses to Revenue | XXX | XXX | 17% | XXX | XXX | XXX |
| G&A Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| R&D Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| Opex to Revenue | XXX | XXX | 27% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| Philips | XXX | XXX | XXX | XXX | XXX | XXX |
| Perspective Therapeutics | XXX | XXX | XXX | XXX | XXX | XXX |
| SmartVest | XXX | XXX | XXX | XXX | XXX | XXX |
| InfuSystem | XXX | XXX | XXX | XXX | XXX | XXX |
| Myomo | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Universal Vision acquired XXX companies to date.
Last acquisition by Universal Vision was XXXXXXXX, XXXXX XXXXX XXXXXX . Universal Vision acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Start Free Trial| When was Universal Vision founded? | Universal Vision was founded in 1994. |
| Where is Universal Vision headquartered? | Universal Vision is headquartered in Taiwan. |
| How many employees does Universal Vision have? | As of today, Universal Vision has 325 employees. |
| Is Universal Vision publicy listed? | Yes, Universal Vision is a public company listed on ROCO. |
| What is the stock symbol of Universal Vision? | Universal Vision trades under 3218 ticker. |
| When did Universal Vision go public? | Universal Vision went public in 2004. |
| Who are competitors of Universal Vision? | Similar companies to Universal Vision include e.g. Philips, Perspective Therapeutics, SmartVest, InfuSystem. |
| What is the current market cap of Universal Vision? | Universal Vision's current market cap is $592M |
| What is the current revenue of Universal Vision? | Universal Vision's last 12 months revenue is $145M. |
| What is the current revenue growth of Universal Vision? | Universal Vision revenue growth (NTM/LTM) is 7%. |
| What is the current EV/Revenue multiple of Universal Vision? | Current revenue multiple of Universal Vision is 3.8x. |
| Is Universal Vision profitable? | Yes, Universal Vision is EBITDA-positive (as of the last 12 months). |
| What is the current EBITDA of Universal Vision? | Universal Vision's last 12 months EBITDA is $64.5M. |
| What is Universal Vision's EBITDA margin? | Universal Vision's last 12 months EBITDA margin is 44%. |
| What is the current EV/EBITDA multiple of Universal Vision? | Current EBITDA multiple of Universal Vision is 8.5x. |
| What is the current FCF of Universal Vision? | Universal Vision's last 12 months FCF is $28.5M. |
| What is Universal Vision's FCF margin? | Universal Vision's last 12 months FCF margin is 20%. |
| What is the current EV/FCF multiple of Universal Vision? | Current FCF multiple of Universal Vision is 19.2x. |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
